[Skip to Content]
[Skip to Content Landing]
December 20, 1952


JAMA. 1952;150(16):1617. doi:10.1001/jama.1952.03680160067023

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Importation of New Drugs.  —The procedure governing the importation of new drugs into Great Britain from the United States causes considerable confusion on both sides of the Atlantic. In a lecture, which was recently published in the British Medical Journal, (2:385, 1952) Sir Weldon Dalrymple-Champneys, deputy chief medical officer, Ministry of Health, who is largely responsible for this branch of the ministry's activities, has outlined the present position. The government departments primarily concerned with the importation of drugs are His Majesty's Customs and Excise and the Board of Trade, but they depend on the Ministry of Health for expert advice whenever medical remedies are involved. This applies particularly to "therapeutic substances" as defined by the Therapeutic Substances Act of 1925, i. e., substances "the purity or potency of which cannot be adequately tested by chemical means." Such substances include insulin, penicillin, and blood products. Difficulties arise with preparations

First Page Preview View Large
First page PDF preview
First page PDF preview